Pressure BioSciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details Narrative)

Subsequent Events (Details Narrative) - USD ($)										1 Months Ended		3 Months Ended	11 Months Ended	12 Months Ended
Subsequent Events (Details Narrative) - USD ($)	Mar. 31, 2018	Mar. 12, 2018	Feb. 22, 2018	Feb. 12, 2018	Jan. 19, 2018	Jan. 16, 2018	Jan. 03, 2018	Dec. 12, 2017	Sep. 20, 2017	Mar. 31, 2018	Jan. 31, 2018	Mar. 31, 2018	Feb. 15, 2018	Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2017	Sep. 12, 2017	Aug. 18, 2017	Apr. 19, 2017	Mar. 21, 2017	Mar. 14, 2017	Jul. 22, 2015
Number of common stock shares issued in lieu of cash														$ 46,992	$ 332,696
Debt conversion price per share														$ 7.50
Number of restricted common stock agreed to issue								$ 600,000
Debt instrument, fee amount														$ 40,980
Debt interest rate																	10.00%
Payments for outstanding balance of previous loan														925,541	$ 107,000
Debt principal amount														$ 4,093,500								$ 2,180,000
Number of restricted common stock issued, shares								150,000	4,000
Original issue of discount percentage																	35.00%
Non-Convertible Loan [Member]
Debt interest rate																			10.00%	10.00%	10.00%
Original issue of discount percentage																35.00%			10.00%	10.00%	10.00%
Revolving Note [Member]
Debt principal amount																		$ 3,500,000
Subsequent Event [Member] \| Merchant Agreement [Member] \| Lender [Member]
Received in exchange for rights to all customer receipts			$ 110,000
Payment of other notes			147,400
Collected rate per business day			$ 921
Subsequent Event [Member] \| Revolving Note [Member]
Proceeds from convertible debt										$ 500,000	$ 500,000
Debt principal amount		$ 4,000,000
Subsequent Event [Member] \| Debenture Holders [Member]
Number of common stock shares issued in lieu of cash, shares												12,494
Number of common stock shares issued in lieu of cash												$ 52,371
Subsequent Event [Member] \| Board of Directors [Member]
Number of common stock shares issued in lieu of cash, shares												1,092
Subsequent Event [Member] \| Accredited Investors [Member]
Proceeds from convertible debt	$ 150,000
Debt, term	6 months
Original issue discount, percentage	10.00%									10.00%		10.00%
Subsequent Event [Member] \| Accredited Investor [Member] \| Non-Convertible Loan [Member]
Proceeds from convertible debt													$ 170,000
Debt, term				8 months
Number of restricted common stock issued, shares				3,500
Number of restricted common stock shares yet to be issued	3,500
Subsequent Event [Member] \| Accredited Investor [Member] \| Convertible Loan [Member]
Proceeds from convertible debt		$ 253,000		$ 100,000	$ 150,000	$ 131,250	$ 95,000
Debt, term		6 months		6 months	6 months	1 year
Debt conversion, original debt, amount		$ 53,000
Debt conversion price per share		$ 7.50		$ 7.50	$ 7.50
Number of restricted common stock agreed to issue		$ 6,750			$ 4,000
Debt interest rate				10.00%	10.00%	4.00%	5.00%
Payments for outstanding balance of previous loan				$ 50,000
Number of restricted common stock issued, shares				5,000
Original issue of discount percentage					10.00%
Debt converted into common stock, percentage						4.00%	40.00%
Subsequent Event [Member] \| Privately-held Investment Firm [Member] \| Convertible Loan [Member]
Proceeds from convertible debt		85,000
Debt instrument, fee amount		$ 5,400